iShares U.S. Pharmaceutical ETF
BlackRock, Inc. IHE ETF
| IHE Price | $100.37 |
Market Cap | $1.29B |
| Annual Dividend Yield | 1.44% |
Annual Dividend | $1.47 |
| Yearly Management Fee | 0.38% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharmaceuticals |
Last 24h Volume | $1.02M |
| Portfolio Management Company | BlackRock, Inc. |
Discount/Premium to NAV | 0.05% |
| Inception Date | May 01, 2006 |
Market Cap Rank | 892 |
| Monthly AUM Growth | 37.46% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Non-Leveraged |
iShares U.S. Pharmaceutical ETF is an ETF issued by BlackRock, Inc. on May 01 2006.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of IHE ETF according to its net asset value is premiumed at 0.05%.
While the total value of the fund shows $351.32M increase compared to the previous month, its price is traded daily at a decrease of -1.81%.
The annual dividend yield of IHE ETF is 1.44%, whereas its main asset area is North America.
IHE ETF, whose 24-hour total volume is $1.02M, has experienced a $260.7M cash inflow in the last month.
In addition, iShares U.S. Pharmaceutical ETF's one-year net asset value total return is 54.65%.
IHE ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -1.81% |
1.46% |
6.67% |
13.08% |
17.16% |
18.04% |
49.45% |
IHE ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 9.28% |
16.14% |
21.28% |
54.65% |
85.02% |
78.36% |
IHE ETF Comments
no comments yet